Watch a replay of the HPS Corporate Lending Fund Fourth Quarter and Full Year 2024 Shareholder Update Webcast

Portfolio

HLEND seeks to build a diversified portfolio of senior secured private credit investments in resilient, market-leading, upper-middle market companies that operate primarily in non-cyclical sectors.

Data as of January 31, 2025

$16.9B

Investments at Fair Value

10.2%

Portfolio Yield at Fair Value1

92%

Private Investments2

97%

First Lien Exposure3

99%

Floating Rate4

$220M

Weighted Average EBITDA5

Portfolio Companies89

Clear Filters
Company Name
Industry
Investment Type
Reference Rate & Spread
Par Amount (thousands)
Amortized Cost (thousands)
Fair Value (thousands)
% of Total Portfolio
AMR GP Limited (Aston Martin Formula 1 Team) Media 1st Lien Senior Secured Debt 10.50% (incl 5.25% PIK) $1,030 1,001 1,024 0.01%
Arc Media Holdings Limited Media 1st Lien Senior Secured Debt SF + 7.25% $42,680 41,659 42,023 0.25%
Aventine Intermediate LLC (Blackstone Media) Media 1st Lien Senior Secured Debt SF + 6.00% (incl 3.00% PIK) $20,767 20,597 19,829 0.12%
LOCI Bidco Limited (Law Business Research) Media 1st Lien Senior Secured Debt SN + 5.25% £73,522 91,319 90,866 0.54%
OneTeam Partners, LLC (OneTeam Partners) Media Preferred Equity 8.00% $1,000 1,000 1,217 0.01%
Racing Point UK Holdings Limited (Aston Martin Formula 1 Team) Media Equity and other investments £10 1,008 977 0.01%
Renaissance Financiere (Ligue de Football) Media 1st Lien Senior Secured Debt E + 7.00% €34,871 35,648 35,236 0.21%
Renaissance Holding Corp. (Renaissance Learning, Inc.) Media 1st Lien Senior Secured Debt SF + 4.00% $7,900 7,766 7,903 0.05%
ABB/CON-CISE Optical Group LLC (ABB Optical) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 7.50% $21,259 20,971 19,632 0.12%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Medical Equipment and Services 1st Lien Senior Secured Debt E + 5.25% €63,105 65,195 65,384 0.39%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 5.25% $125,859 90,741 93,465 0.55%
DCA Acquisition Holdings LLC (Dental Care Alliance) Medical Equipment and Services Unsecured Debt 13.13% PIK $1,505 1,484 1,198 0.01%
Endeavor Operating Co LLC (ENDEAVOR OPERATING CO) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 3.00% $8,219 8,178 8,240 0.05%
Femur Buyer, Inc. (Orchid Orthopedic Solutions, LLC) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 8.25% (incl 4.50% PIK) $142,359 139,422 140,221 0.83%
Limpio Bidco GMBH (Schülke & Mayr) Medical Equipment and Services 1st Lien Senior Secured Debt E + 5.20% €63,783 65,929 67,396 0.40%
PerkinElmer U.S. LLC (PerkinElmer) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 5.00% $239,943 218,532 225,551 1.34%
Plasma Buyer LLC (Path Group Inc.) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 5.75% $92,668 87,345 85,824 0.51%
Plasma Buyer LLC (Path Group Inc.) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 6.25% $3,140 2,465 2,430 0.01%
Resonetics, LLC Medical Equipment and Services 1st Lien Senior Secured Debt SF + 3.25% $38,540 38,452 38,880 0.23%
SDC US Smilepay SPV (SmileDirectClub) Medical Equipment and Services 1st Lien Senior Secured Debt P + 9.75% $14,456 7,510 2,861 0.02%
Spruce Bidco II Inc. (Vantive) Medical Equipment and Services 1st Lien Senior Secured Debt CORRA + 5.00% CAD 35,000 23,803 23,719 0.14%
Spruce Bidco II Inc. (Vantive) Medical Equipment and Services 1st Lien Senior Secured Debt T + 5.75% (incl 3.13% PIK) ¥3,744,213 23,814 23,773 0.14%
Viant Medical Holdings, Inc. (Viant) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 4.00% $17,500 17,415 17,765 0.11%
Vital Care Buyer, LLC (Vital Care Inc) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 4.50% $103,533 89,302 90,262 0.53%
Zeus Company LLC (Zeus Company Inc.) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 5.50% $168,075 129,357 133,026 0.79%

Engage with HLEND

Start Here

Footnotes

  1. Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts and less any annual amortization of premiums, as applicable, on accruing (i) debt and (ii) other income producing securities, divided by (b) total accruing (i) debt and (ii) other income producing securities (at fair value). Actual yields earned over the life of each investment could differ materially from the yields presented above. Please refer to HLEND’s prospectus and filings, including Form 10-Q or Form 10-K for fair value disclosures.
  2. Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Private investments includes investments in joint ventures.
  3. Based on the aggregate fair value of the investment portfolio as of January 31, 2025.
  4. Percentage based on aggregate fair value of accruing debt.
  5. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets and investments in joint ventures. In the case of weighted average EBITDA only, excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis, such as loan-to-value-based loans, NAV-based loans or reorganized equity. Weighted average EBITDA is weighted based on the fair value of the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the fair value of the total applicable level 3 debt investments. Excludes investments on non-accrual status as of October 31, 2024. Figures are derived from the most recent financial statements from portfolio companies.
  6. Includes “last out” portions of first lien senior secured loans.
  7. Secured debt at the holding company level.
  8. Based on FTSE / DJ Industry Classification Benchmark (“ICB”) sector definition. Totals may not sum due to rounding.
  9. All figures are as of January 31, 2025 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.
  10. Other includes structured finance investments.